Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-18-012091

Options or other derivatives

  • COO, CSO acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Cavanagh William COO, CSO 2018-06-13 Grant or award · Stock Options (right to buy) +150,000 401,660 D
Loading xslF345X03/rdgdoc.xml…